Want to see ADMA full AI Analyst Report?
ADMA Biologics (ADMA) Q2 2024 Earnings Report
ADMA Q2 2024 EPS Results
- Actual EPS
- $0.14
- Consensus EPS
- $0.08
- Beat/Miss
- Beat by +$0.06
- One Year Ago EPS
- -$0.02
ADMA Q2 2024 Revenue Results
- Actual Revenue
- $107.19M
- Expected Revenue
- $86.42M
- Beat/Miss
- Beat by +$20.77M
- YoY Revenue Growth
- +78.29%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/08/2024
- Time
- After Close
- Conference Call
- Thursday, August 8, 2024
ADMA Upcoming Earnings
ADMA Biologics's next earnings date is estimated for November 4, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
ADMA Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
ADMA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 04, 2026 | 2026 (Q3) | 0.20- | 0.16 | ― | ― |
| Aug 05, 2026 | 2026 (Q2) | 0.160.17 | 0.15 | 12.24% (+0.02) | |
| May 06, 2026 | 2026 (Q1) | 0.190.17 | 0.14 | 25.74% (+0.04) | |
| Feb 25, 2026 | 2025 (Q4) | 0.180.21 | 0.14 | 51.06% (+0.07) | |
| Nov 05, 2025 | 2025 (Q3) | 0.150.16 | 0.16 | -1.84% (-0.00) | |
| Aug 06, 2025 | 2025 (Q2) | 0.140.15 | 0.14 | 3.52% (+0.01) | |
| May 07, 2025 | 2025 (Q1) | 0.150.14 | 0.09 | 52.81% (+0.05) | |
| Mar 03, 2025 | 2024 (Q4) | 0.150.14 | -0.08 | 276.25% (+0.22) | |
| Nov 07, 2024 | 2024 (Q3) | 0.130.16 | 0.01 | 1530.00% (+0.15) | |
| Aug 08, 2024 | 2024 (Q2) | 0.080.14 | -0.02 | 888.89% (+0.16) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
